SCOR Global Life increasingly is recognized as a key participant in the life reinsurance market worldwide. We were pleased to see that SCOR’s geographic scope was implicit in Standard & Poor’s upgrade of the company to AA- this past September. The ratings agency specifically acknowledged SCOR Global Life’s presence in the Americas as a key
component of the company overall. The benefits of a financially strong risk partner cannot be understated, but we also should consider the value that this global position contributes to our clients beyond the balance sheet.
For purposes of this newsletter I wish to focus specifically on the value that our global community of medical directors and underwriters add to the success of SCOR Global Life and to our clients. Our Americas staff relied on our colleagues in Europe for important updates to our disability insurance manual. We looked to our peers in Asia to improve our critical illness capabilities. In turn, our Americas teams shares critical insight in mortality assessment, particularly from the perspective of a market with multiple risk classes.
We also have seen this collaboration in this newsletter. Earlier this year we were pleased to have Dr. Evans, a cardiologist in our Paris office, contribute his specialized knowledge about patent foramen ovale. In this issue we welcome Dr. Gabriela Buffet, an Associate Medical Director and specialist in infectious disease on our Paris-based Research & Development team.
Dr. Buffet was vital in following the recent Ebola outbreak and keeping the company and clients apprised of the risks. With a medical degree from South America, Dr. Buffet represents the growing global nature of the insurance medicine practice and SCOR’s commitment to medical R&D.
In this final issue for 2015 we present two more uncommon medical conditions for your consideration. HTLV 1 infection is endemic to some areas but usually goes unrecognized until a complication develops. Cardiac papillary fibroelastoma is simply rare. And our newsletter would not be complete without Dr. Rooney’s Underwriting Puzzler.
On behalf of Dr. Rooney and SCOR’s medical staff worldwide, I’d like to wish you and your company a prosperous New Year. We appreciate the trust you have placed with us, and we look forward to serving you in 2016 and beyond.